Cargando…
Microbial and genetic-based framework identifies drug targets in inflammatory bowel disease
Rationale: With increasing incidence and prevalence of inflammatory bowel disease (IBD), it has become one of the major public health threats, and there is an urgent need to develop new therapeutic agents. Although the pathogenesis of IBD is still unclear, previous research has provided evidence for...
Autores principales: | Wang, Zhihan, Guo, Kai, Gao, Pan, Pu, Qinqin, Lin, Ping, Qin, Shugang, Xie, Na, Hur, Junguk, Li, Changlong, Huang, Canhua, Wu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210594/ https://www.ncbi.nlm.nih.gov/pubmed/34158863 http://dx.doi.org/10.7150/thno.59196 |
Ejemplares similares
-
Identification of Repurposable Drugs and Adverse Drug Reactions for Various Courses of COVID-19 Based on Single-Cell RNA Sequencing Data
por: Wang, Zhihan, et al.
Publicado: (2020) -
Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications
por: Wang, Zhihan, et al.
Publicado: (2021) -
oprC Impairs Host Defense by Increasing the Quorum-Sensing-Mediated Virulence of Pseudomonas aeruginosa
por: Gao, Pan, et al.
Publicado: (2020) -
Apolipoprotein E in Asthmatic Inflammatory Response: Friend or
Foe?
por: Qin, Shugang, et al.
Publicado: (2020) -
Interaction among inflammasome, autophagy and non-coding RNAs: new horizons
for drug
por: Pu, Qinqin, et al.
Publicado: (2019)